Multiparametric Cardiovascular MRI Assessment of Post-COVID Syndrome in Children in Comparison to Matched Healthy Individuals.
Journal
Investigative radiology
ISSN: 1536-0210
Titre abrégé: Invest Radiol
Pays: United States
ID NLM: 0045377
Informations de publication
Date de publication:
18 Dec 2023
18 Dec 2023
Historique:
medline:
20
12
2023
pubmed:
20
12
2023
entrez:
20
12
2023
Statut:
aheadofprint
Résumé
Post-COVID syndrome (PCS) can adversely affect the quality of life of patients and their families. In particular, the degree of cardiac impairment in children with PCS is unknown. The aim of this study was to identify potential cardiac inflammatory sequelae in children with PCS compared with healthy controls. This single-center, prospective, intraindividual, observational study assesses cardiac function, global and segment-based strains, and tissue characterization in 29 age- and sex-matched children with PCS and healthy children using a 3 T magnetic resonance imaging (MRI). Cardiac MRI was carried out over 36.4 ± 24.9 weeks post-COVID infection. The study cohort has an average age of 14.0 ± 2.8 years, for which the majority of individuals experience from fatigue, concentration disorders, dyspnea, dizziness, and muscle ache. Children with PSC in contrast to the control group exhibited elevated heart rate (83.7 ± 18.1 beats per minute vs 75.2 ± 11.2 beats per minute, P = 0.019), increased indexed right ventricular end-diastolic volume (95.2 ± 19.2 mlm-2 vs 82.0 ± 21.5 mlm-2, P = 0.018) and end-systolic volume (40.3 ± 7.9 mlm-2 vs 34.8 ± 6.2 mlm-2, P = 0.005), and elevated basal and midventricular T1 and T2 relaxation times (P < 0.001 to P = 0.013). Based on the updated Lake Louise Criteria, myocardial inflammation is present in 20 (69%) children with PCS. No statistically significant difference was observed for global strains. Cardiac MRI revealed altered right ventricular volumetrics and elevated T1 and T2 mapping values in children with PCS, suggestive for a diffuse myocardial inflammation, which may be useful for the diagnostic workup of PCS in children.
Sections du résumé
BACKGROUND
BACKGROUND
Post-COVID syndrome (PCS) can adversely affect the quality of life of patients and their families. In particular, the degree of cardiac impairment in children with PCS is unknown.
OBJECTIVE
OBJECTIVE
The aim of this study was to identify potential cardiac inflammatory sequelae in children with PCS compared with healthy controls.
METHODS
METHODS
This single-center, prospective, intraindividual, observational study assesses cardiac function, global and segment-based strains, and tissue characterization in 29 age- and sex-matched children with PCS and healthy children using a 3 T magnetic resonance imaging (MRI).
RESULTS
RESULTS
Cardiac MRI was carried out over 36.4 ± 24.9 weeks post-COVID infection. The study cohort has an average age of 14.0 ± 2.8 years, for which the majority of individuals experience from fatigue, concentration disorders, dyspnea, dizziness, and muscle ache. Children with PSC in contrast to the control group exhibited elevated heart rate (83.7 ± 18.1 beats per minute vs 75.2 ± 11.2 beats per minute, P = 0.019), increased indexed right ventricular end-diastolic volume (95.2 ± 19.2 mlm-2 vs 82.0 ± 21.5 mlm-2, P = 0.018) and end-systolic volume (40.3 ± 7.9 mlm-2 vs 34.8 ± 6.2 mlm-2, P = 0.005), and elevated basal and midventricular T1 and T2 relaxation times (P < 0.001 to P = 0.013). Based on the updated Lake Louise Criteria, myocardial inflammation is present in 20 (69%) children with PCS. No statistically significant difference was observed for global strains.
CONCLUSIONS
CONCLUSIONS
Cardiac MRI revealed altered right ventricular volumetrics and elevated T1 and T2 mapping values in children with PCS, suggestive for a diffuse myocardial inflammation, which may be useful for the diagnostic workup of PCS in children.
Identifiants
pubmed: 38117123
doi: 10.1097/RLI.0000000000001048
pii: 00004424-990000000-00183
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
Conflicts of interest and sources of funding: Ministry for Science and Culture of Lower Saxony in Germany (grant number: ZN3894); Radiological Cooperative Network (RACOON) of the Network University Medicine (NUM) under the BMBF grant numbers 01KX2021 and 01KX2121.
Références
Puntmann VO, Martin S, Shchendrygina A, et al. Long-term cardiac pathology in individuals with mild initial COVID-19 illness. Nat Med. 2022;28:2117–2123.
Raman B, Bluemke DA, Luscher TF, et al. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J. 2022;43:1157–1172.
Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5:1265–1273.
Zimmermann P, Pittet LF, Curtis N. How common is long COVID in children and adolescents? Pediatr Infect Dis J. 2021;40:e482–e487.
Liu K, Yu J, Song G. Global myocardial strain in multisystem inflammatory syndrome in children, Kawasaki disease, and healthy children: a network meta-analysis. Front Pediatr. 2022;10:848306.
Ahmed S, Strait K, RayChaudhuri N, et al. Global longitudinal strain reduction in the absence of clinical cardiac symptoms in multisystem inflammatory syndrome in children associated with COVID-19: a case series. Pediatr Cardiol. 2022;43:233–237.
Bartoszek M, Malek LA, Barczuk-Falecka M, et al. Cardiac magnetic resonance follow-up of children after pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 with initial cardiac involvement. J Magn Reson Imaging. 2022;55:883–891.
Aiyegbusi OL, Hughes SE, Turner G, et al. Symptoms, complications and management of long COVID: a review. J R Soc Med. 2021;114:428–442.
National Institute for Health and Care Excellence (NICE). COVID-19 rapid guideline: managing the long-term effects of COVID-19. 2020. Available at: https://www.ncbi.nlm.nih.gov/books/NBK567261/. Accessed September 26, 2023.
Gorecka M, Jex N, Thirunavukarasu S, et al. Cardiovascular magnetic resonance imaging and spectroscopy in clinical long-COVID-19 syndrome: a prospective case-control study. J Cardiovasc Magn Reson. 2022;24:50.
Eckstein J, Korperich H, Paluszkiewicz L, et al. Multi-parametric analyses to investigate dependencies of normal left atrial strain by cardiovascular magnetic resonance feature tracking. Sci Rep. 2022;12:12233.
Giusca S, Steen H, Montenbruck M, et al. Multi-parametric assessment of left ventricular hypertrophy using late gadolinium enhancement, T1 mapping and strain-encoded cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2021;23:92.
Holtackers RJ, Wildberger JE, Wintersperger BJ, et al. Impact of field strength in clinical cardiac magnetic resonance imaging. Invest Radiol. 2021;56:764–772.
Venkatesan P. NICE guideline on long COVID. Lancet Respir Med. 2021;9:129.
Messroghli DR, Greiser A, Frohlich M, et al. Optimization and validation of a fully-integrated pulse sequence for modified look-locker inversion-recovery (MOLLI) T1 mapping of the heart. J Magn Reson Imaging. 2007;26:1081–1086.
Bauner KU, Biffar A, Theisen D, et al. Extracellular volume fractions in chronic myocardial infarction. Invest Radiol. 2012;47:538–545.
Weise Valdes E, Barth P, Piran M, et al. Left-ventricular reference myocardial strain assessed by cardiovascular magnetic resonance feature tracking and fSENC-impact of temporal resolution and cardiac muscle mass. Front Cardiovasc Med. 2021;8:764496.
Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Int J Cardiovasc Imaging. 2002;18:539–542.
Blondiaux E, Parisot P, Redheuil A, et al. Cardiac MRI in children with multisystem inflammatory syndrome associated with COVID-19. Radiology. 2020;297:E283–E288.
Ferreira VM, Schulz-Menger J, Holmvang G, et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol. 2018;72:3158–3176.
Liljequist D, Elfving B, Skavberg Roaldsen K. Intraclass correlation—a discussion and demonstration of basic features. PloS One. 2019;14:e0219854.
Broberg CS, Chugh SS, Conklin C, et al. Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease. Circ Cardiovasc Imaging. 2010;3:727–734.
Chen CA, Dusenbery SM, Valente AM, et al. Myocardial ECV fraction assessed by CMR is associated with type of hemodynamic load and arrhythmia in repaired tetralogy of Fallot. JACC Cardiovasc Imaging. 2016;9:1–10.
Dusenbery SM, Jerosch-Herold M, Rickers C, et al. Myocardial extracellular remodeling is associated with ventricular diastolic dysfunction in children and young adults with congenital aortic stenosis. J Am Coll Cardiol. 2014;63:1778–1785.
Andre F, Steen H, Matheis P, et al. Age- and gender-related normal left ventricular deformation assessed by cardiovascular magnetic resonance feature tracking. J Cardiovasc Magn Reson. 2015;17:25.
Levy S, Heiss R, Grimm R, et al. Free-breathing low-field MRI of the lungs detects functional alterations associated with persistent symptoms after COVID-19 infection. Invest Radiol. 2022;57:742–751.
McElvaney OJ, McEvoy NL, McElvaney OF, et al. Characterization of the inflammatory response to severe COVID-19 illness. Am J Respir Crit Care Med. 2020;202:812–821.
Sanner BM, Konermann M, Tepel M, et al. Platelet function in patients with obstructive sleep apnoea syndrome. Eur Respir J. 2000;16:648–652.
Aquaro GD, Ghebru Habtemicael Y, Camastra G, et al. Prognostic value of repeating cardiac magnetic resonance in patients with acute myocarditis. J Am Coll Cardiol. 2019;74:2439–2448.
Latus H, Gummel K, Klingel K, et al. Focal myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in children and adolescents with dilated cardiomyopathy. J Cardiovasc Magn Reson. 2015;17:34.
Ulanowska M, Olas B. Modulation of hemostasis in COVID-19; blood platelets may be important pieces in the COVID-19 puzzle. Pathogens. 2021;10:370.
Perricone C, Bartoloni E, Bursi R, et al. COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy. Immunol Res. 2020;68:213–224.
Roca-Fernandez A, Wamil M, Telford A, et al. Cardiac abnormalities in long COVID 1-year post-SARS-CoV-2 infection. Open. Heart. 2023;10.
Sarıçam E, Dursun AD, Türkmen Sarıyıldız G, et al. Laboratory and imaging evaluation of cardiac involvement in patients with post-acute COVID-19. Int J Gen Med. 2021;14:4977–4985.
Pretorius E, Vlok M, Venter C, et al. Persistent clotting protein pathology in long COVID/post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol. 2021;20:172.
Kell DB, Laubscher GJ, Pretorius E. A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications. Biochem J. 2022;479:537–559.
Raveendran AV, Misra A. Post COVID-19 syndrome (“long COVID”) and diabetes: challenges in diagnosis and management. Diabetes Metab Syndr. 2021;15:102235.